
Sign up to save your podcasts
Or
Erin McCreary (@erinmccreary) and Ryan Shields (@ryankshields) review results of ASPECT-NP (Ceftolozane-tazobactam versus meropenem in patients with ventilated nosocomial pneumonia), CAMERA-2 (Combination therapy for methicillin-resistant Staphylococcus aureus bacteraemia), and Exebacase for patients with methicillin-resistant Staphylococcus aureus bacteraemia (Phase 2).
Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About
4.9
159159 ratings
Erin McCreary (@erinmccreary) and Ryan Shields (@ryankshields) review results of ASPECT-NP (Ceftolozane-tazobactam versus meropenem in patients with ventilated nosocomial pneumonia), CAMERA-2 (Combination therapy for methicillin-resistant Staphylococcus aureus bacteraemia), and Exebacase for patients with methicillin-resistant Staphylococcus aureus bacteraemia (Phase 2).
Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About
2,054 Listeners
1,869 Listeners
316 Listeners
130 Listeners
25 Listeners
3,321 Listeners
1,101 Listeners
251 Listeners
366 Listeners
187 Listeners
25 Listeners
83 Listeners
235 Listeners
8 Listeners
3 Listeners